naltrexone and Cancer of Testis

naltrexone has been researched along with Cancer of Testis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andersson, H; Floettmann, E; Johnson, N; Mitchard, T	1

Other Studies

1 other study(ies) available for naltrexone and Cancer of Testis

Article	Year
Naloxegol, an opioid antagonist with reduced CNS penetration: Mode-of-action and human relevance for rat testicular tumours. Toxicology and applied pharmacology, 2017, 08-15, Volume: 329 Topics: Animals; Biomarkers; Blood-Brain Barrier; Capillary Permeability; Dogs; Female; Humans; Leydig Cell Tumor; Luteinizing Hormone; Male; Mice; Morphinans; Naltrexone; Narcotic Antagonists; Polyethylene Glycols; Quaternary Ammonium Compounds; Rabbits; Rats, Sprague-Dawley; Risk Assessment; Species Specificity; Testicular Neoplasms; Testosterone; Time Factors; Toxicity Tests; Up-Regulation	2017

Article

Year

Naloxegol, an opioid antagonist with reduced CNS penetration: Mode-of-action and human relevance for rat testicular tumours.

Toxicology and applied pharmacology, 2017, 08-15, Volume: 329

Topics: Animals; Biomarkers; Blood-Brain Barrier; Capillary Permeability; Dogs; Female; Humans; Leydig Cell Tumor; Luteinizing Hormone; Male; Mice; Morphinans; Naltrexone; Narcotic Antagonists; Polyethylene Glycols; Quaternary Ammonium Compounds; Rabbits; Rats, Sprague-Dawley; Risk Assessment; Species Specificity; Testicular Neoplasms; Testosterone; Time Factors; Toxicity Tests; Up-Regulation

2017